ACORDA THERAPEUTICS INC
CUSIP 00484MAC0
Acorda Therapeutics Inc has 8 institutional holders in Filings Flow’s 13F database, together reporting 196.93M shares worth $113M as of Q1 2024. The largest reported holders are Highbridge Capital Management LLC, Davidson Kempner Capital Management LP, and Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (LLC).
Institutional Holders
8
Q1 2024
Reported Value
$113M
Ticker
unmapped
private placement or foreign
Quarters Tracked
13
Ownership Trend
Institutional holders
Total reported value
Holders
··
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC$3.1B AUM | 1.14% | $31M | 45.28M | Q1 2024 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP$7.3B AUM | 0.30% | $23M | 52.32M | Q1 2024 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)$3.4B AUM | 0.57% | $20M | 30.00M | Q1 2024 |
| SOROS FUND MANAGEMENT LLC$9.1B AUM | 0.26% | $16M | 27.95M | Q1 2024 |
| CANYON CAPITAL ADVISORS LLC$772M AUM | 1.46% | $14M | 25.88M | Q1 2024 |
| D. E. Shaw & Co., Inc.$166.3B AUM | 0.01% | $8M | 14.00M | Q1 2024 |
| Saltoro Capital, LP$30,000 AUM | 1.08% | $855,000 | 1.50M | Q1 2024 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM | — | $0 | 0 | Q1 2024 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.